摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(5-(4-iodophenyl)oxazol-2-yl)pyridine

中文名称
——
中文别名
——
英文名称
4-(5-(4-iodophenyl)oxazol-2-yl)pyridine
英文别名
5-(4-Iodophenyl)-2-pyridin-4-yl-1,3-oxazole
4-(5-(4-iodophenyl)oxazol-2-yl)pyridine化学式
CAS
——
化学式
C14H9IN2O
mdl
——
分子量
348.143
InChiKey
FTUYBNGASDYTNY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    38.9
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
    申请人:Mendoza Serafin Jose
    公开号:US20080015193A1
    公开(公告)日:2008-01-17
    Certain oxazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, methods of using compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions comprising compounds exhibiting ATP-utilizing enzyme inhibitory activity, are disclosed.
    本发明涉及一些呈现出ATP利用酶抑制活性的噁唑基化合物,使用呈现出ATP利用酶抑制活性的化合物的方法,以及包含呈现出ATP利用酶抑制活性的化合物的组合物。
  • ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE
    申请人:Magenta Therapeutics Inc.
    公开号:US20210220408A1
    公开(公告)日:2021-07-22
    The disclosure relates to aryl hydrocarbon receptor antagonists as well as methods of modulating aryl hydrocarbon receptor activity and expanding hematopoietic stem cells by culturing hematopoietic stem or progenitor cells in the presence of these agents. Additionally, the disclosure provides methods of treating various pathologies, such as cancer, by administration of these aryl hydrocarbon receptor antagonists. Additionally, the disclosure provides methods of treating various pathologies in a patient by administration of expanded hematopoietic stem cells. The disclosure further provides kits containing aryl hydrocarbon receptor antagonists that can be used for the expansion of hematopoietic stem cells. The disclosure further relates to pharmaceutical compositions comprising the compounds and methods of treating or preventing a disease in which aryl hydrocarbon receptor plays a role.
  • [EN] CERTAIN AZOLES EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF<br/>[FR] AZOLES DOTÉS D'UNE ACTIVITÉ INHIBITRICE ENZYMATIQUE UTILISANT L'ATP, COMPOSITIONS, ET LEURS UTILISATIONS
    申请人:AMPHORA DISCOVERY CORP
    公开号:WO2007149395A2
    公开(公告)日:2007-12-27
    [EN] Certain oxazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, methods of using compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions comprising compounds exhibiting ATP-utilizing enzyme inhibitory activity, are disclosed.
    [FR] La présente invention concerne des composés à base d'oxazole présentant une activité inhibitrice enzymatique utilisant l'ATP, des procédés d'utilisation des composés présentant une activité inhibitrice enzymatique utilisant l'ATP, et des compositions contenant les composés présentant une activité inhibitrice enzymatique utilisant l'ATP.
查看更多